Browse Health
License & Identifications

A medical license is required for a doctor to practice medicine in a particular state. Requirements vary by state but most require, at a minimum, post-graduate training in the doctor’s specific specialty. An NPI number is a national identifier unique to an individual health care provider and is managed by the Center for Medicare & Medicaid Services (CMS).

Learn more about Dr. Matthew Porteus:

View the full profile to get information on:

  1. Qualifications
  2. What's important to you

View full profile

Patient Reviews

Have you visited Dr. Porteus? Share your experience.
Write a Review

Specialties & Research

Dr. Matthew Porteus, MD, PHD is board certified in Pediatric Hematology-Oncology.

  • He has special expertise in 6 areas:
  • Acute Myeloid Leukemia
  • Cancer
  • Chronic Myeloid Leukemia
  • DNA Damage
  • Gene Therapy
  • Leukemia

Education & Awards

Dr. Porteus graduated from Stanford University. He has 2 awards.

Burroughs Wellcome Fund Career Development Award (2003)
Howard Hughes Medical Institute Postdoctoral Research Fellowship for Physicians (2002)


Dr. Porteus has 8 hospital affiliations:

  • Stanford Hospital and Clinics 
  • Children's Medical Center of Dallas 

> > > > Dr. Matthew Porteus, MD, PHD

Similar doctors nearby

Dr. Kathleen Wiertel

3 years experience
Dallas, TX

Dr. Robert Bash

Pediatric Hematology-Oncology
26 years experience
Dallas, TX

Dr. Martha Stegner

9 years experience
Dallas, TX

Dr. Mohammed Athar

Internal Medicine
Dallas, TX

Dr. Shivani Patel

Internal Medicine
Dallas, TX

Dr. Jacquelyn Ravan Andrews

Surgical Oncology
26 years experience
Dallas, TX
Search All Similar Doctors
Additional Information
Dr. Matthew Hebden Porteus MD and PHD is a male Pediatric Oncologist, has 18 years of experience and practices in Pediatric Hematology-Oncology.
Where does Dr. Matthew H. Porteus practice?
Dr. Matthew Porteus has 1 office location.
Dr. Matthew Porteus practices Pediatric Hematology-Oncology near Dallas, TX.
See Dallas Oncologists.